ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

25 links0 made here, not in the record49 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02813135European Proof-of-ConceptTherapeutic StratificationTrial of MolecularAnomalies in Relapsed orRefractory TumorsGustave Roussy, Cancer Campus,Phase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSNeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSRibociclibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTopotecanIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTemozolomideIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedEverolimusIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAdavosertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCarboplatinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundOlaparibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedIrinotecanIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVistusertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCyclophosphamideIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAZD 6244Entry “Selumetinib”, read by our name…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedEnasidenibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLirilumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCYC065Entry “Fadraciclib”, read by our name…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCytarabineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundDexamethasoneIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCeralasertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedFutibatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCapmatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAvelumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPeposertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCapivasertibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVinorelbineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Ribociclib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Ribociclib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2RibociclibClaude Opus 5.5TestedCurrent
Nov 2TopotecanClaude Opus 5.5TestedCurrent
Nov 2TemozolomideClaude Opus 5.5TestedCurrent
Nov 2EverolimusClaude Opus 5.5TestedCurrent
Nov 2AdavosertibClaude Opus 5.5TestedCurrent
Nov 2CarboplatinClaude Opus 5.5BackgroundCurrent
Nov 2OlaparibClaude Opus 5.5TestedCurrent
Nov 2IrinotecanClaude Opus 5.5TestedCurrent
Nov 2VistusertibClaude Opus 5.5TestedCurrent
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2CyclophosphamideClaude Opus 5.5TestedCurrent
Nov 2AZD 6244Claude Opus 5.5TestedCurrent
Nov 2EnasidenibClaude Opus 5.5TestedCurrent
Nov 2LirilumabClaude Opus 5.5TestedCurrent
Nov 2CYC065Claude Opus 5.5TestedCurrent
Nov 2CytarabineClaude Opus 5.5BackgroundCurrent
Nov 2DexamethasoneClaude Opus 5.5BackgroundCurrent
Nov 2CeralasertibClaude Opus 5.5TestedCurrent
Nov 2FutibatinibClaude Opus 5.5TestedCurrent
Nov 2CapmatinibClaude Opus 5.5TestedCurrent
Nov 2AvelumabClaude Opus 5.5TestedCurrent
Nov 2PeposertibClaude Opus 5.5TestedCurrent
Nov 2CapivasertibClaude Opus 5.5TestedCurrent
Nov 2VinorelbineClaude Opus 5.5BackgroundCurrent
Nov 18RibociclibRule based · role ruleTestedAgrees
Nov 18TopotecanRule based · role ruleTestedAgrees
Nov 18TemozolomideRule based · role ruleTestedAgrees
Nov 18EverolimusRule based · role ruleTestedAgrees
Nov 18AdavosertibRule based · role ruleTestedAgrees
Nov 18CarboplatinRule based · role ruleBackgroundAgrees
Nov 18OlaparibRule based · role ruleTestedAgrees
Nov 18IrinotecanRule based · role ruleTestedAgrees
Nov 18VistusertibRule based · role ruleTestedAgrees
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18CyclophosphamideRule based · role ruleTestedAgrees
Nov 18AZD 6244Rule based · role ruleTestedAgrees
Nov 18EnasidenibRule based · role ruleTestedAgrees
Nov 18LirilumabRule based · role ruleTestedAgrees
Nov 18CYC065Rule based · role ruleTestedAgrees
Nov 18CytarabineRule based · role ruleBackgroundAgrees
Nov 18DexamethasoneRule based · role ruleBackgroundAgrees
Nov 18CeralasertibRule based · role ruleTestedAgrees
Nov 18FutibatinibRule based · role ruleTestedAgrees
Nov 18CapmatinibRule based · role ruleTestedAgrees
Nov 18AvelumabRule based · role ruleTestedAgrees
Nov 18PeposertibRule based · role ruleTestedAgrees
Nov 18CapivasertibRule based · role ruleTestedAgrees
Nov 18VinorelbineRule based · role ruleBackgroundAgrees
As of nowNeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.